Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility

Abstract Significant individual susceptibility to intravenous anesthetic propofol exists. The etiology of individual variability in the response to propofol may be influenced by genetic polymorphisms in metabolic and functional pathways. With current pharmacogenetics and modern molecular biology tec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qi Zhong, Xiangdong Chen, Yan Zhao, Ru Liu, Shanglong Yao
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4d074c98dc3c4f4386470cadba238ca8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4d074c98dc3c4f4386470cadba238ca8
record_format dspace
spelling oai:doaj.org-article:4d074c98dc3c4f4386470cadba238ca82021-12-02T12:30:33ZAssociation of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility10.1038/s41598-017-03229-32045-2322https://doaj.org/article/4d074c98dc3c4f4386470cadba238ca82017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03229-3https://doaj.org/toc/2045-2322Abstract Significant individual susceptibility to intravenous anesthetic propofol exists. The etiology of individual variability in the response to propofol may be influenced by genetic polymorphisms in metabolic and functional pathways. With current pharmacogenetics and modern molecular biology technologies, it is possible to study the influence of genetic polymorphisms on susceptibility to propofol. When inducing general anesthesia with intravenous propofol, high individual susceptibility to propofol was found. Using Sequenom MassARRAY single-nucleotide polymorphism (SNP) genotyping, we identified a mutation (rs6313) in the 5HT2A gene that was correlated to individual susceptibility to propofol effect-site concentration (Cep) and onset time of propofol induction. Carriers of the minor allele (G) of 5HT2A rs6313 required less propofol (20% decrease in Cep) and less time (40% decrease in onset time) to induce anesthesia. Moreover, associations were found between the gamma-aminobutyric acid (GABA) receptor SNP rs2279020 and the SCN9A SNP rs6746030 and the susceptibility of bispectral index (BIS) after propofol-induced anesthesia. In addition, dominant mutations in GABAA1 rs2279020, GABAA2 rs11503014, and CHRM2 rs1824024 were putatively associated with cardiovascular susceptibility to propofol anesthesia. No gene-gene interactions were found through a standardized measure of linkage disequilibrium and a multifactor dimensionality reduction analysis. Our results suggest that genetic polymorphisms related to mechanisms of propofol anesthesia are involved in propofol susceptibility.Qi ZhongXiangdong ChenYan ZhaoRu LiuShanglong YaoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-16 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Qi Zhong
Xiangdong Chen
Yan Zhao
Ru Liu
Shanglong Yao
Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility
description Abstract Significant individual susceptibility to intravenous anesthetic propofol exists. The etiology of individual variability in the response to propofol may be influenced by genetic polymorphisms in metabolic and functional pathways. With current pharmacogenetics and modern molecular biology technologies, it is possible to study the influence of genetic polymorphisms on susceptibility to propofol. When inducing general anesthesia with intravenous propofol, high individual susceptibility to propofol was found. Using Sequenom MassARRAY single-nucleotide polymorphism (SNP) genotyping, we identified a mutation (rs6313) in the 5HT2A gene that was correlated to individual susceptibility to propofol effect-site concentration (Cep) and onset time of propofol induction. Carriers of the minor allele (G) of 5HT2A rs6313 required less propofol (20% decrease in Cep) and less time (40% decrease in onset time) to induce anesthesia. Moreover, associations were found between the gamma-aminobutyric acid (GABA) receptor SNP rs2279020 and the SCN9A SNP rs6746030 and the susceptibility of bispectral index (BIS) after propofol-induced anesthesia. In addition, dominant mutations in GABAA1 rs2279020, GABAA2 rs11503014, and CHRM2 rs1824024 were putatively associated with cardiovascular susceptibility to propofol anesthesia. No gene-gene interactions were found through a standardized measure of linkage disequilibrium and a multifactor dimensionality reduction analysis. Our results suggest that genetic polymorphisms related to mechanisms of propofol anesthesia are involved in propofol susceptibility.
format article
author Qi Zhong
Xiangdong Chen
Yan Zhao
Ru Liu
Shanglong Yao
author_facet Qi Zhong
Xiangdong Chen
Yan Zhao
Ru Liu
Shanglong Yao
author_sort Qi Zhong
title Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility
title_short Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility
title_full Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility
title_fullStr Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility
title_full_unstemmed Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility
title_sort association of polymorphisms in pharmacogenetic candidate genes with propofol susceptibility
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/4d074c98dc3c4f4386470cadba238ca8
work_keys_str_mv AT qizhong associationofpolymorphismsinpharmacogeneticcandidategeneswithpropofolsusceptibility
AT xiangdongchen associationofpolymorphismsinpharmacogeneticcandidategeneswithpropofolsusceptibility
AT yanzhao associationofpolymorphismsinpharmacogeneticcandidategeneswithpropofolsusceptibility
AT ruliu associationofpolymorphismsinpharmacogeneticcandidategeneswithpropofolsusceptibility
AT shanglongyao associationofpolymorphismsinpharmacogeneticcandidategeneswithpropofolsusceptibility
_version_ 1718394333257793536